Additionally, there is an immediate demand for the creation and application of reliable, standardized biomarkers of aging to assess therapeutic effectiveness not through clinical indicators of metabolic regulation, but through biological aging
"Our goal remains the same: to maximize access to safe, FDA-approved medications through a frictionless virtual care experience that delivers long-term and sustainable weight loss and health benefits for our patients. LifeMDs shift from compounded GLP-1s to direct partnerships with leading pharmaceutical manufacturers is central to its long-term growth strategy, reinforcing its commitment to emerging regulatory and reimbursement frameworks and to meeting rising demand for authentic obesity and metabolic care medications
It's a more accessible one
doi:10.1111/1753-0407.12398 Lee YS & Jun HS (2014)
It may just be my imagination, but it also smells a little, well, citrus-y
Berutti is a huge asset in Dr Berutti is amazing